This inventor holds 31 USPTO granted patents and 8 published patent applications and 2 EPO patents, primarily in Antiviral Agents. Top assignee: Enanta Pharmaceuticals, Inc.. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2026
Areas of Expertise:
Title: Innovations and Contributions of Wei Li in Antiviral Research
Introduction
Wei Li, a prominent inventor based in Lexington, MA, has made significant strides in the field of antiviral research, holding an impressive portfolio of 25 patents. His work primarily focuses on developing innovative compounds that target various viruses, contributing to advancements in pharmaceutical therapies.
Latest Patents
Wei Li's latest patents showcase his dedication to combating viral infections. One of his recent inventions involves Spiropyrrolidine-derived antiviral agents, which are designed to inhibit the replication activity of picornavirus, norovirus, and coronavirus. This invention outlines pharmaceutical compositions that utilize these compounds and provides methods for treating or preventing viral infections through effective administration.
In addition to this, he has developed antiviral agents specifically targeting Hepatitis B virus (HBV). His research culminated in the disclosure of compounds that inhibit the proteins encoded by HBV or interfere with its life cycle, proving essential in the fight against HBV infections. The patent also details pharmaceutical compositions for treating subjects afflicted with HBV, highlighting significant therapeutic potential.
Career Highlights
Wei Li’s career at Enanta Pharmaceuticals, Inc. underscores his commitment to innovation in drug development. Through his research and patent applications, he has contributed to the advancement of medical therapies that address critical public health issues, particularly in the area of viral infections.
Collaborations
Collaboration is a key aspect of research, and Wei Li has worked alongside esteemed colleagues such as Hui Cao and Xiaowen Peng. Together, they have fostered an environment of innovation, facilitating the development of groundbreaking antiviral agents through combined expertise.
Conclusion
In summary, Wei Li's contributions to antiviral research exemplify the importance of innovation and collaboration in the field of pharmaceuticals. With a robust patent portfolio and a commitment to addressing viral infections, Wei Li continues to play a pivotal role in advancing medical treatments that may benefit countless individuals worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile